ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT06779773 updates: 1. completion date: 2030-01-31 → 2030-10-31 2. primary completion date: 2030-01-31 → 2030-10-31 3. enrollment: 1000 → 500 participants
Clinical trial NCT06779773 updates: 1. completion date: 2030-01-31 → 2030-10-31 2. primary completion date: 2030-01-31 → 2030-10-31 3. enrollment: 1000 → 500 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical